$CURLF

Curaleaf (CURA) urged Aurora (ACB) shareholders to accept its hostile takeover bid, offering a 45% premium. Curaleaf claims the deal would create a global cannabis leader with $1.5B revenue and $350M EBITDA. Aurora's management advises shareholders to reject the offer, citing inadequate value and risks.

Curaleaf Holdings proposed acquiring Aurora Cannabis for $4.21 per share, a 51% premium. The deal combines cash and stock, aiming to create a global cannabis leader. Curaleaf expects growth from its scale and Aurora's assets, with U.S. regulatory catalysts as a tailwind.

Curaleaf Holdings opened three new dispensaries in Connecticut, Pennsylvania, and Florida, increasing its total locations to 179. The company relocated stores in Meriden, CT, and Philadelphia, PA, and opened a new one in Port Richey, FL. CEO Boris Jordan highlighted the strategic importance of these locations for expanding market presence and serving patient demand.

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) opened a new dispensary in Port Richey, Florida, bringing its total to 78 in the state and 179 nationwide. The company's CEO highlighted Florida's importance as a medical cannabis market and its commitment to expanding access. The new location offers a range of products and will host a grand opening event.

Curaleaf (TSX: CURA, OTCQX: CURLF) urged Aurora Cannabis shareholders to accept its offer, offering a 45% premium. The combined entity would have $1.5B revenue and $350M adjusted EBITDA. Curaleaf CEO Boris Jordan will host a Q&A on September 17.

Curaleaf (CURA.T) has made a hostile takeover bid for Aurora Cannabis (ACB.T), offering 0.3463 Curaleaf shares plus US$0.75 cash per Aurora share, implying a value of approximately US$4.00 per Aurora share. Aurora's board recommends rejecting the offer, citing Curaleaf's debt and Aurora's debt-free status. The deal is subject to regulatory conditions and has a cap at US$5.00 per share.

Curaleaf (CURLF) filed an application with the Alberta Securities Commission to halt Aurora's (ACB) at-the-market share issuance program, arguing it dilutes shareholders and increases the cost of Curaleaf's offer. Aurora has issued ~2.81M shares since Curaleaf's interest, diluting shareholders by ~4.9% and raising the offer cost by over US$11M. Curaleaf seeks an expedited hearing to protect Aurora shareholders.

Curaleaf subsidiaries GR Vending MI and CURA MI won a federal appeals court case, reversing a $31.8 million jury award to Hello Farms Licensing MI over a 2020 marijuana contract dispute. The court ruled federal courts cannot enforce contracts involving illegal marijuana activity. Curaleaf supports cannabis reform.

Curaleaf Holdings (CURLF) defended its $4.00-$5.00 takeover bid for Aurora Cannabis, citing a 45% premium and better financial performance. Aurora rejected the offer, and Curaleaf urged a shorter bid period. The deal, if successful, would be transformative for Curaleaf but faces opposition and dilution risks.

Curaleaf (CURLF) issued a fact sheet defending its $4.00 offer for Aurora, stating it implies a 45% cash premium and up to 110% excluding Aurora's cash. The company accused Aurora of dilutive issuances and contrasted its positive operating cash flow with Aurora's negative cash flow. Curaleaf also defended the deal structure, citing a $5.00 cap in the 92nd percentile of Canadian M&A premiums.